C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
about
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerBiology of MET: a double life between normal tissue repair and tumor progressionC1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activityDecreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.Protein glycosylation in cancer.Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathwayDifferential N-Glycosylation Patterns in Lung Adenocarcinoma TissueMucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylationBiomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerQuercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.The extent of whole-genome copy number alterations predicts aggressive features in primary melanomas.Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.PNGase F-mediated incorporation of (18)O into glycans for relative glycan quantitation.Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling.The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities
P2860
Q26751472-BE01B5AF-0726-4C5B-86D4-0B28DE380F78Q28085247-E8BF9153-0A56-4F05-A88F-3B400C57373CQ33688535-7EF9EAEB-509E-4969-AF02-6E2F629DD5F2Q33999174-A6722A93-6F10-4AA3-9DCD-5CE6E767A3CDQ34958488-661381EB-4178-4923-B7F9-B7EF454E13C1Q35413473-CA9325E6-C0EA-4CE3-975B-FC98F3FB9245Q35742481-9097294D-CC4A-4F5E-961A-AD1B4A7AAF4AQ36278033-1CA5F830-A7E1-4CC5-B02D-FED4810075CAQ36998213-71CD7347-90FC-43F0-A1DC-67D8CABBCAF5Q37472263-0C79EC50-3F70-4397-9E0B-A105E59F99D4Q38544783-54193ECD-A1D7-4EBE-A792-B5ADAD8342F3Q38875292-6A12C24D-D937-451B-8D43-8E43193B9523Q40314697-6C91E5E1-3811-4711-BC17-BD0C66E33D7BQ40938494-DC9F9469-4E2E-456A-B8BC-96E221898B52Q41672972-DB257E3C-6F2A-49AB-9194-7654F2503297Q45711994-932B1E11-2BF6-469A-9122-72FEC56CA87FQ49805726-AF4E6DC9-3870-44A9-A274-5C2B9896611BQ57494132-820C6EEF-B3E7-4507-A68B-B6605827C490
P2860
C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@en
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@nl
type
label
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@en
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@nl
prefLabel
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@en
C1GALT1 enhances proliferation ...... lycosylation and dimerization.
@nl
P2093
P50
P1433
P1476
C1GALT1 enhances proliferation ...... glycosylation and dimerization
@en
P2093
Chiung-Hui Liu
Miao-Juei Huang
Min-Chuan Huang
P304
P356
10.1158/0008-5472.CAN-13-0869
P407
P577
2013-07-05T00:00:00Z